Schonfeld Strategic Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 23,839 shares of APLS stock, worth $813,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,839
Previous 31,566 24.48%
Holding current value
$813,863
Previous $1.21 Million 43.22%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$28.84 - $41.15 $222,846 - $317,966
-7,727 Reduced 24.48%
23,839 $687,000
Q2 2024

Aug 14, 2024
BUY
$38.07 - $59.71 $1.2 Million - $1.88 Million
31,566 New
31,566 $1.21 Million
Q3 2023

Nov 14, 2023
SELL
$23.65 - $89.22 $3.86 Million - $14.5 Million
-163,003 Reduced 99.27%
1,200 $45,000
Q2 2023

Aug 14, 2023
BUY
$76.68 - $93.31 $6.76 Million - $8.23 Million
88,176 Added 115.98%
164,203 $15 Million
Q1 2023

May 15, 2023
BUY
$46.59 - $66.96 $2.78 Million - $3.99 Million
59,627 Added 363.58%
76,027 $5.01 Million
Q4 2022

Feb 14, 2023
SELL
$43.24 - $61.04 $2.95 Million - $4.17 Million
-68,289 Reduced 80.64%
16,400 $848,000
Q3 2022

Nov 14, 2022
SELL
$44.76 - $69.66 $582,640 - $906,764
-13,017 Reduced 13.32%
84,689 $5.78 Million
Q2 2022

Aug 15, 2022
BUY
$35.07 - $59.21 $3.43 Million - $5.79 Million
97,706 New
97,706 $4.42 Million
Q1 2022

May 16, 2022
SELL
$35.46 - $54.12 $4.2 Million - $6.42 Million
-118,558 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$30.74 - $49.16 $3.3 Million - $5.27 Million
107,258 Added 949.19%
118,558 $5.61 Million
Q3 2021

Nov 16, 2021
SELL
$31.4 - $69.84 $666,747 - $1.48 Million
-21,234 Reduced 65.27%
11,300 $373,000
Q2 2021

Nov 16, 2021
SELL
$40.9 - $64.9 $204,500 - $324,500
-5,000 Reduced 13.32%
32,534 $2.06 Million
Q2 2021

Aug 16, 2021
BUY
$40.9 - $64.9 $962,499 - $1.53 Million
23,533 Added 168.08%
37,534 $2.37 Million
Q1 2021

May 17, 2021
SELL
$40.8 - $57.39 $996,784 - $1.4 Million
-24,431 Reduced 63.57%
14,001 $601,000
Q4 2020

Feb 16, 2021
BUY
$30.79 - $57.2 $1.18 Million - $2.2 Million
38,432 New
38,432 $2.2 Million
Q1 2020

May 15, 2020
SELL
$17.91 - $44.33 $735,509 - $1.82 Million
-41,067 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$22.1 - $30.8 $907,580 - $1.26 Million
41,067 New
41,067 $1.26 Million
Q3 2018

Nov 14, 2018
SELL
$16.57 - $21.03 $344,175 - $436,814
-20,771 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$19.63 - $30.0 $407,734 - $623,130
20,771 New
20,771 $457,000

Others Institutions Holding APLS

# of Institutions
309
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.75B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email